Prosecution Insights
Last updated: April 19, 2026
Application No. 18/742,210

SYSTEM, METHOD, AND APPARATUS FOR ELECTRONIC PATIENT CARE

Final Rejection §DP
Filed
Jun 13, 2024
Examiner
LAM, ELIZA ANNE
Art Unit
3681
Tech Center
3600 — Transportation & Electronic Commerce
Assignee
Deka Products Limited Partnership
OA Round
4 (Final)
38%
Grant Probability
At Risk
5-6
OA Rounds
4y 6m
To Grant
68%
With Interview

Examiner Intelligence

Grants only 38% of cases
38%
Career Allow Rate
207 granted / 547 resolved
-14.2% vs TC avg
Strong +30% interview lift
Without
With
+30.3%
Interview Lift
resolved cases with interview
Typical timeline
4y 6m
Avg Prosecution
36 currently pending
Career history
583
Total Applications
across all art units

Statute-Specific Performance

§101
27.6%
-12.4% vs TC avg
§103
37.8%
-2.2% vs TC avg
§102
17.6%
-22.4% vs TC avg
§112
14.1%
-25.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 547 resolved cases

Office Action

§DP
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claims 1-18 and 37-38 rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-8 of U.S. Patent No. 12,070,572, claims 1-20 of U.S. Patent 11,524,107, and claims 1-32 of U.S. Patent 10,453,157. Although the claims at issue are not identical, they are not patentably distinct from each other because they are directed to a narrower embodiment of the invention of 12,070,572, 11,524,107, and 10,453,157 and contain all of the same limitations. Allowable Subject Matter Claims 1-18 and 37-38 would be allowable if the double patenting rejection set forth in this Office action was overcome. Conclusion THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Peter Choi can be reached on 469-295-9171. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ELIZA A LAM/ Primary Examiner, Art Unit 3681
Read full office action

Prosecution Timeline

Jun 13, 2024
Application Filed
Jan 25, 2025
Non-Final Rejection — §DP
Apr 24, 2025
Response Filed
May 07, 2025
Final Rejection — §DP
Jun 24, 2025
Request for Continued Examination
Jun 30, 2025
Response after Non-Final Action
Jul 16, 2025
Non-Final Rejection — §DP
Sep 08, 2025
Interview Requested
Sep 18, 2025
Response Filed
Sep 18, 2025
Applicant Interview (Telephonic)
Sep 18, 2025
Examiner Interview Summary
Jan 05, 2026
Final Rejection — §DP (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12597488
USE OF MACHINE LEARNING MODELS FOR PREDICTION OF CLINICAL OUTCOMES
2y 5m to grant Granted Apr 07, 2026
Patent 12573492
Method for evaluating the body activity of a user
2y 5m to grant Granted Mar 10, 2026
Patent 12573488
SYSTEM AND METHOD FOR PERSONALIZED DOSING OF PHARMACOLOGIC AGENTS
2y 5m to grant Granted Mar 10, 2026
Patent 12561996
METHODS AND SYSTEMS FOR REDISTRIBUTING MEDICATION
2y 5m to grant Granted Feb 24, 2026
Patent 12525335
COMPUTERIZED SYSTEMS FOR PREDICTION OF GEOGRAPHIC ATROPHY PROGRESSION USING DEEP LEARNING APPLIED TO CLINICAL IMAGING
2y 5m to grant Granted Jan 13, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

5-6
Expected OA Rounds
38%
Grant Probability
68%
With Interview (+30.3%)
4y 6m
Median Time to Grant
High
PTA Risk
Based on 547 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month